An Overview of Notable Data from the 2024 San Antonio Breast Cancer Symposium
By Karine Tawagi, MD - Last Updated: December 19, 2024Adam Brufsky, MD, PhD, who was on hand at the 2024 San Antonio Breast Cancer Symposium (SABCS) spoke to Karine Tawagi, MD, of Two Onc Docs, about notable data presented at the 2024 SABCS and they mean for physicians in the breast cancer space.
Advertisement
Advertisement
Related Posts
Dr. Adam Brufsky details to Dr. Karine Tawagi what separates SABCS from other conferences when it comes to breast cancer.
Researchers sought to assess the rate of axillary pCR in TNBC patients.
Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes.
Researchers assessed the real-world treatment patterns and clinical outcomes of HER+ BC brain metastases.
Individuals with metaplastic breast cancer (MpBC) show a distinct molecular phenotype.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.